Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by gebremeskelon Nov 28, 2019 1:28pm

111 Views

Post# 30402765

RE:RE:Interim Financial Statements Tomorrow?

Theralase often sticks in a few info goodies in the MD&A file.

Hempdoc wrote: Financials should be coming in, but should have no impact...LLLT is status quo as is the cash burn rate for the trial. However, hope we find a good partner for other indications...don't want to see too much more dilution.

Bullboard Posts

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)